Skip to main content

GAXOS.AI INC.

For the period ended Mar 31, 2026. Filed May 14, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 14, 2026

GXAI$0.39+7.7%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Consolidated Balance Sheets as of March 31, 2026 (Unaudited) and December 31, 2025

CONSOLIDATED BALANCE SHEETS

March 31,December 31,
20262025
(Unaudited)
ASSETS
CURRENT ASSETS:
Cash$1,513,550$840,799
Short-term investments, at fair value10,195,79111,345,187
Investment in equity securities, at fair value106,000180,000
Accounts receivable80,49876,247
Prepaid expenses and other current assets261,051157,586
Total Current Assets12,156,89012,599,819
LONG-TERM ASSETS:
Property and equipment, net90,386103,393
Intangible assets, net673,433718,333
Investment in cost method investee2,900,000-
Total Long-Term Assets3,663,819821,726
TOTAL ASSETS$15,820,709$13,421,545
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable$228,043$270,105
Accrued expenses98,958280,430
Deferred revenue242,307130,054
Total Current Liabilities569,308680,589
Total Liabilities569,308680,589
Commitments and Contingencies (See Note 7)
STOCKHOLDERS’ EQUITY:
Preferred stock; par value $0.0001; 5,000,000 shares authorized; No shares issued and outstanding on March 31, 2026 and December 31, 2025--
Common stock; par value $0.0001: 50,000,000 shares authorized; 10,219,934 and 7,123,453 shares issued and outstanding on March 31, 2026 and December 31, 2025, respectively1,022712
Additional paid-in capital31,170,78725,801,322
Accumulated other comprehensive income(358,108)26,976
Accumulated deficit(14,872,829)(12,700,304)
Total Gaxos.AI Stockholders’ Equity15,940,87213,128,706
Noncontrolling interest(689,471)(387,750)
Total Stockholders’ Equity15,251,40112,740,956
Total Liabilities and Stockholders’ Equity$15,820,709$13,421,545

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

For the Three Months Ended
March 31,
20262025
REVENUES$1,809,367$23,732
OPERATING EXPENSES:
Research and development446,422220,989
Selling, general and administrative3,910,0671,194,438
Total Operating Expenses4,356,4891,415,427
LOSS FROM OPERATIONS(2,547,122)(1,391,695)
OTHER INCOME (LOSS):
Interest income158,110148,188
Unrealized loss on short-term investments(21,945)-
Unrealized loss on equity securities(74,000)-
Realized gain on short-term investments10,71111,445
Total other income, net72,876159,633
NET LOSS(2,474,246)(1,232,062)
Net loss of subsidiary attributable to noncontrolling interest301,72140,262
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS$(2,172,525)$(1,191,800)
COMPREHENSIVE LOSS:
Net loss$(2,474,246)$(1,232,062)
Other comprehensive income:
Unrealized loss on short-term debt investments(385,084)(69,040)
Comprehensive loss$(2,859,330)$(1,301,102)
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS:
Basic and diluted$(0.25)$(0.17)
WEIGHTED AVERAGE COMMON SHARE OUTSTANDING:
Basic and diluted8,649,0127,001,231

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025

Additional · Accumulated Other · Total
Preferred Stock · Common Stock · Paid-in · Comprehensive · Accumulated · Noncontrolling · Stockholders’
# of Shares · Amount · # of Shares · Amount · Capital · Income (Loss) · Deficit · Interest · Equity
Balance, December 31, 2025-$-7,123,453$712$25,801,322$26,976$(12,700,304)$(387,750)$12,740,956
Common shares issued for cash, net--3,096,4813105,315,599---5,315,909
Accretion of stock option expense----53,866---53,866
Accumulated other comprehensive loss - short-term investments-----(385,084)--(385,084)
Net loss------(2,172,525)(301,721)(2,474,246)
Balance, March 31, 2026-$-10,219,934$1,022$31,170,787$(358,108)$(14,872,829)$(689,471)$15,251,401
Additional · Accumulated Other · Total
Preferred Stock · Common Stock · Paid-in · Comprehensive · Accumulated · Noncontrolling · Stockholders’
# of Shares · Amount · # of Shares · Amount · Capital · Income (Loss) · Deficit · Interest · Equity
Balance, December 31, 2024--6,923,45369225,416,45111,693(8,799,721)(6,086)16,623,029
Common shares issued for intangible asset--200,00020247,980---248,000
Accretion of stock option expense----32,880---32,880
Accumulated other comprehensive loss - short-term investments-----(69,040)--(69,040)
Net loss------(1,191,800)(40,262)(1,232,062)
Balance, March 31, 2025-$-7,123,453$712$25,697,311$(57,347)$(9,991,521)$(46,348)$15,602,807
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.